Clinical features and “early” corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia
暂无分享,去创建一个
Jinrong Liu | Shunying Zhao | Liyong Liu | R. He | Xiaoyan Zhang | Fei Zhao | He Wang
[1] Zhimin Chen,et al. Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management , 2022, Journal of clinical medicine.
[2] Jianzhong Zhang,et al. Molecular features and antimicrobial susceptibility of Mycoplasma pneumoniae isolates from pediatric inpatients in Weihai, China. , 2022, Journal of global antimicrobial resistance.
[3] Tongqiang Zhang,et al. Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children , 2021, Frontiers in Pediatrics.
[4] Jinrong Liu,et al. Proteomics study of Mycoplasma pneumoniae pneumonia reveals the Fc fragment of the IgG-binding protein as a serum biomarker and implicates potential therapeutic targets , 2021, Frontiers of Medicine.
[5] Jianzhong Zhang,et al. First report of macrolide resistant and susceptible Mycoplasma pneumoniae clinical strains isolated from one case. , 2021, Journal of global antimicrobial resistance.
[6] Jinrong Liu,et al. Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia , 2020, Frontiers in Cellular and Infection Microbiology.
[7] Jian Deng,et al. Roles of the mammalian target of rapamycin (mTOR) signaling pathway in the repair of hyperoxia-induced acute lung injury. , 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[8] Jinrong Liu,et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital , 2020, BMC infectious diseases.
[9] Jinrong Liu,et al. High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia , 2019, BMC Infectious Diseases.
[10] H. Kang,et al. Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children , 2019, Journal of clinical medicine.
[11] Jinrong Liu,et al. Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016 , 2019, Antimicrobial Resistance & Infection Control.
[12] Jinrong Liu,et al. Clinicoradiologic features of Mycoplasma pneumoniae bronchiolitis in children , 2018, Pediatric investigation.
[13] Jinrong Liu,et al. Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients , 2018, Front. Pediatr..
[14] T. Krunkosky,et al. Modelling persistent Mycoplasma pneumoniae infection of human airway epithelium , 2018, Cellular microbiology.
[15] Marjolein J. W. de Bruijn,et al. The Role of B Cells in Carriage and Clearance of Mycoplasma pneumoniae From the Respiratory Tract of Mice , 2018, The Journal of infectious diseases.
[16] Jinrong Liu,et al. Mycoplasma pneumoniae–Associated Bronchiolitis Obliterans Following Acute Bronchiolitis , 2017, Scientific Reports.
[17] Chuangli Hao,et al. The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children , 2016, Scientific Reports.
[18] H. Kang,et al. Long-term azithromycin ameliorates not only airway inflammation but also remodeling in a murine model of chronic asthma. , 2016, Pulmonary pharmacology & therapeutics.
[19] X. Tao,et al. Culture-Independent Detection and Genotyping of Mycoplasma pneumoniae in Clinical Specimens from Beijing, China , 2015, PloS one.
[20] Jinrong Liu,et al. [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children]. , 2014, Zhonghua er ke za zhi = Chinese journal of pediatrics.
[21] H. Kil,et al. Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children , 2013, Allergy, asthma & immunology research.
[22] K. Shen,et al. Combination therapy with immune‐modulators and moxifloxacin on fulminant macrolide‐resistant Mycoplasma pneumoniae infection: A case report , 2013, Pediatric pulmonology.
[23] Jinrong Liu,et al. [Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia]. , 2012, Zhonghua er ke za zhi = Chinese journal of pediatrics.
[24] Takashi Shimizu,et al. Cytoadherence‐dependent induction of inflammatory responses by Mycoplasma pneumoniae , 2011, Immunology.
[25] T. Fukaya,et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children , 2008, Journal of Infection.
[26] C. Salvatore,et al. Intranasal Interleukin-12 Therapy Inhibits Mycoplasma pneumoniae Clearance and Sustains Airway Obstruction in Murine Pneumonia , 2007, Infection and Immunity.
[27] D. Burgner,et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children , 2006, Pediatric pulmonology.
[28] A. Mejias,et al. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. , 2005, American journal of respiratory cell and molecular biology.
[29] E. Ruchelli,et al. Bronchitis obliterans due to Mycoplasma pneumonia , 1997, Pediatric pulmonology.
[30] [Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)]. , 2013, Zhonghua er ke za zhi = Chinese journal of pediatrics.